Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Mysugr GmbH operates within the Medical Devices & Mechanical Engineering technology area with a portfolio currently managing 2 pending office actions. These actions are distributed across 2 distinct examiners and 2 distinct art units. This distribution indicates that the company's legal challenges or applications are being reviewed by multiple specialized departments within the patent office, rather than being confined to a single point of contact. The presence of 2 distinct art units suggests that the underlying technologies may span different classifications within the broader medical device sector.
The busiest examiner identified in the data is HOFFPAUIR, ANDREW ELI, who is responsible for 1 pending action. This means that the remaining 1 pending office action is assigned to the other distinct examiner involved in the portfolio. For practitioners, this spread requires monitoring multiple examination styles and art unit specificities simultaneously. The outcome of the company's current patent efforts depends on the interactions within these 2 distinct administrative channels and the standards of the Medical Devices & Mechanical Engineering division.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (50%) |
| §103 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOFFPAUIR, ANDREW ELI | 1 | 41.4% | +52.1% |
| SKIBINSKY, ANNA | 1 | 39.0% | +29.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17487940 | METHOD AND SYSTEM FOR DETERMINING A RELATIVE RISK FOR LACK OF GLYCEMIC CONTROL FOR A PLURALITY OF PATIENTS | HOFFPAUIR, ANDREW ELI | 89d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17487940 | METHOD AND SYSTEM FOR DETERMINING A RELATIVE RISK FOR LACK OF GLYCEMIC CONTROL FOR A PLURALITY OF PATIENTS | HOFFPAUIR, ANDREW ELI | 89d overdue |
| 17313660 | METHOD AND SYSTEM OF DETERMINING A PROBABILITY OF A BLOOD GLUCOSE VALUE FOR A PATIENT BEING IN AN ADVERSE BLOOD GLUCOSE RANGE AT A PREDICTION TIME | SKIBINSKY, ANNA | 68d |
| Art Unit | Apps |
|---|---|
| 3791 | 1 |
| 1635 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17487940 | METHOD AND SYSTEM FOR DETERMINING A RELATIVE RISK FOR LACK OF GLYCEMIC CONTROL FOR A PLURALITY OF PATIENTS | HOFFPAUIR, ANDREW ELI | 3791 | §101 | Non-Final OA | 89d overdue | Pending | Sep 28, 2021 |
| 17313660 | METHOD AND SYSTEM OF DETERMINING A PROBABILITY OF A BLOOD GLUCOSE VALUE FOR A PATIENT BEING IN AN ADVERSE BLOOD GLUCOSE RANGE AT A PREDICTION TIME | SKIBINSKY, ANNA | 1635 | §103 | Non-Final OA | 68d | Pending | May 06, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial